Veerhealth Care Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Veerhealth Care Ltd. on BSE

Load latest

Veerhealth Care Ltd.

04 Aug 2025

19.31

-0.21%

Investor Presentation

Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Investors Presentation of the Company. The presentation is also being made available on the Company''s website www.veerhealthcare.net.

pdf

Veerhealth Care Ltd.

01 Aug 2025

19.31

-0.21%

Board Meeting

Veerhealth Care Ltd - 511523 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial …

BSE India

Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve 1. Unaudited financial results of the Company for the quarter ended 30th June, 2025. 2. Draft Director's Report for the financial year ending 31st March, 2025. 3. Draft notice convening 33rd Annual General Meeting of the Company.

pdf

Veerhealth Care Ltd.

29 Jul 2025

19.31

-0.21%

Company Update

Veerhealth Care Ltd - 511523 - Updates

BSE India

We are pleased to share a glimpse of our newly renovated and expanded factory, following the successful closure of the USFDA audit. This milestone marks a significant step forward in our commitment to excellence and compliance. We invite all our valued shareholders to explore more through the link www.veerhealthcare.net.

pdf

Veerhealth Care Ltd.

25 Jul 2025

19.31

-0.21%

Company Update

Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

We are enclosing herewith the Press Release on receipt of regulatory approval and first commercial order from leading marketplace Company.

pdf

Veerhealth Care Ltd.

23 Jul 2025

19.31

-0.21%

Company Update

Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

BSE India

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that in continuation to our intimation dated 7th July, 2025, Company has received mandatory regulatory approval from the Food and Drug Authority, Gujarat for manufacturing and supply of personal care products for one of the India''s leading marketplace company. In addition to the regulatory approval, Company has also received its first commercial order for manufacture and supply of products in personal care category. This order is for products in skin care and face care segment and going forward more products would be added to the contract manufacturing portfolio.

pdf

Veerhealth Care Ltd.

22 Jul 2025

19.31

-0.21%

Company Update

Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

We are enclosing herewith the Press Release on execution and receipt of orders post USFDA approval.

pdf

Veerhealth Care Ltd.

21 Jul 2025

19.31

-0.21%

Company Update

Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

BSE India

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that following the receipt of approval from the United States Food and Drug Administration (USFDA) for our products registered under DUG (OTC), the Company has commenced execution of orders for the said products in the U.S. market. The USFDA approval was received on 16th May, 2025 and commercial execution of orders has commenced by execution of 3 FCL shipments till date and now with the receipt of new orders from the customer, Company targets to dispatch 4 to 5 shipments on monthly basis to the US customer. This development is expected to contribute positively to the Company''s revenues and presence in the regulated market.

pdf

Veerhealth Care Ltd.

09 Jul 2025

19.31

-0.21%

Company Update

Veerhealth Care Ltd - 511523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

We are enclosing herewith the Press Release on Contract Manufacturing Agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products.

pdf

Veerhealth Care Ltd.

07 Jul 2025, 12:20PM

19.31

-0.21%

Company Update

Veerhealth Care Ltd - 511523 - Announcement Under Regulation 30 (LODR) - Contract Manufacturing Agreement With …

BSE India

Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that company has entered into a strategic Contract Manufacturing Agreement with a company having top position in personal care segment on marketplace companies in the country for the production of its private-label personal care range of products.

pdf

Veerhealth Care Ltd.

04 Jul 2025

19.31

-0.21%

Company Update

Veerhealth Care Ltd - 511523 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Pursuant to Regulation 74(5) of the SEBI (DP) Regulations, 2018, please find attached herewith the certificate received from M/s. Purva Sharegistry (India) Private Limited, the Registrar and Share Transfer Agent of the Company, for the quarter ended 30th June, 2025.

pdf

Is Veerhealth Care Ltd. worth buying?

25 Votes:

Buy 52.0%

Sell 24.0%

Hold 24.0%